Skip to main content
Premium Trial:

Request an Annual Quote

VA, Polymedco Ink Deal for Colorectal Cancer Testing

NEW YORK (GenomeWeb News) – Polymedco announced today that two of its colorectal cancer screening products will now be available through the US Department of Veterans Affairs (VA) healthcare system.

Under the terms of the five-year contract, VA patients will have access to Eiken Chemical's OC-Light S manual fecal immunochemical test (FIT), as well as Epigenomics' Epi proColon colorectal cancer screen. Polymedco is the US distributor for the FIT and co-markets Epi proColon under a 2013 agreement with Epigenomics.

Additional terms of the contract were not disclosed.

Polymedco's OC-Auto automated FIT system is already available at VA facilities under an existing arrangement.

"We are excited to continue our relationship with the [VA] and pleased to be able to offer them our complete offering of colorectal cancer screening tools," Polymedco President Drew Cervasio said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.